ClinVar Miner

Submissions for variant NM_001113378.2(FANCI):c.2879_2884dup (p.Gln961_Phe962insTrpGln)

gnomAD frequency: 0.00001  dbSNP: rs776851666
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV001806727 SCV002050923 likely benign not specified 2021-12-10 criteria provided, single submitter clinical testing Variant summary: FANCI c.2879_2884dupGGCAAT (p.Gln961_Phe962insTrpGln) results in an in-frame insertion that is predicted to insert two amino acids into the encoded protein. The variant allele was found at a frequency of 6e-05 in 251284 control chromosomes, predominantly at a frequency of 0.00082 within the East Asian subpopulation in the gnomAD database. The observed variant frequency within East Asian control individuals in the gnomAD database is approximately 2.9-fold of the estimated maximal expected allele frequency (MPAF) for a pathogenic variant in FANCI causing the Fanconi Anemia phenotype (0.00028). However, in the Korean subpopulation the variant was reported with an even higher allele frequency 0.0029 (i.e. 11 / 3818 alleles) that is ~10-fold higher than the estimated MPAF, strongly suggesting that the variant is a benign polymorphism found primarily in populations of East Asian origin. The variant, c.2879_2884dupGGCAAT, has been reported in the literature in two East Asian individuals affected with acute myeloid leukemia (Jeong_2019) and breast cancer (Yang_2015), however these reports do not provide unequivocal conclusions about association of the variant with Fanconi Anemia. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely benign.
Labcorp Genetics (formerly Invitae), Labcorp RCV001869492 SCV002286146 uncertain significance Fanconi anemia 2024-01-04 criteria provided, single submitter clinical testing This variant, c.2879_2884dup, results in the insertion of 2 amino acid(s) of the FANCI protein (p.Gln961_Phe962insTrpGln), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs776851666, gnomAD 0.08%). This variant has been observed in individual(s) with acute myeloid leukemia (PMID: 31470354). ClinVar contains an entry for this variant (Variation ID: 1331383). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Fulgent Genetics, Fulgent Genetics RCV005005288 SCV005631045 uncertain significance Fanconi anemia complementation group I 2024-04-23 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.